TD Cowen had upgraded Merck in early 2024 based on confidence in Keytruda and Gardasil’s performance, a lack of binary risks, and an attractive valuation. However, setbacks in Gardasil’s China ...

Investing.com -- TD Cowen downgraded Merck & Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

Investing.com -- TD Cowen downgraded Merck &Company Inc (NYSE:MRK) to "Hold" on concerns over uncertainty surrounding Gardasil sales, a slowdown in business development, and the looming loss of ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

TD Cowen initiated coverage of Repligen (RGEN) with a Buy rating and $200 price target Repligen is well positioned for “industry-leading” growth and margin expansion as it is over-indexed ...

TD Cowen reaffirmed their buy rating on shares of Tempus AI (NASDAQ:TEM – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. TD Cowen currently has a $74.00 ...

We recently compiled a list of the 11 AI News and Ratings You Shouldn't Miss. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against the other AI stocks ...

On Monday, TD Cowen's analysts adjusted their outlook on Neste Oyj (NESTE:FH) (OTC: NTOIY), reducing the price target from €19.00 to €15.00 while maintaining a Hold rating on the stock.

On February 6, TD Cowen analyst Krish Sankar maintained a Buy rating on ARM Holdings with a $200 price target, due to strong growth potential. The company exceeded December quarter revenue ...

TD Cowen began coverage on shares of Palvella Therapeutics (NASDAQ:PVLA – Free Report) in a research report released on Wednesday morning, MarketBeat.com reports. The firm issued a buy rating ...

On Monday, TD Cowen's analysts adjusted their outlook on Neste Oyj (NESTE:FH) (OTC: NTOIY), reducing the price target from €19.00 to €15.00 while maintaining a Hold rating on the stock. The stock, ...